ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Sr. Director, Global Engineering and EHS at Keenova Therapeutics and Par Health - ApplyBlast

Sr. Director, Global Engineering and EHS

Keenova Therapeutics and Par Health

1 day ago

3.4 on Glassdoor

Hazelwood, Missouri, United States

Hybrid

Full Time

Director

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Senior Director of Global Engineering & EHS leads all aspects of Engineering and Environmental Health & Safety for Par Health, overseeing capital budget management, project implementation, and technical support across the manufacturing network. The role involves developing and implementing EHS strategies, ensuring regulatory compliance, and fostering a culture of safety and continuous improvement. This position requires strategic vision and hands-on implementation to protect the workforce and the environment while aligning resources with business goals.

Responsibilities

Lead global engineering and EHS operations across the manufacturing network
Manage capital budget and oversee implementation of capital projects
Develop and implement EHS strategies to ensure regulatory compliance and safety

Skills

Qualifications

BS in Mechanical/Electrical EngineeringBS in EHSBS in Chemistryadvanced degree

About Keenova Therapeutics and Par Health

mallinckrodt.com

Headquarters

Dublin, Dublin, Ireland

Company Size

1001-5000 employees

Founded

1867

View Profile

Keenova Therapeutics and Par Health are the successor entities formed after Mallinckrodt's merger with Endo; Keenova Therapeutics focuses on specialty therapeutics across rare and unaddressed conditions (immunology, urology, hepatology, ophthalmology, orthopedics, critical care), while Par Health develops high-quality generics, sterile injectables, and active pharmaceutical ingredients (APIs) with a robust U.S.-advantaged manufacturing network.